December i went to a prom i was the equivalent of a freshman oft the university and i came home at 2 00 oclock at night and the light was on interested americas and the war. And why did i get you so much. Because i knew we were going to lose it. What did that mean for you. I did not cry them. How old were you, i was 17,. With the late author john lucas indepth was born 20 years ago since 2000 over 200 of the nonfiction and fiction authors of our time have appeared on indepth alice, bob woodward, tyson, george will, just to name a few over the next three hours our goal is to review the last years of indepth and ask a couple of questions, here they are, who is your favorite indepth guest, what book are you reading now and he was your favorite Nonfiction Author, thats what will be talking about and showing a video from the past 20 years as well and heres how you can dial in on the 20th anniversary of indepth to 027488200 and for those of you in the mountain in Eastern Central time zone 20
And allowing the government to negotiate medication Prescription Drug prices. And for residents and homers to stay in their homes during the pandemic. Live coverage of the house. The speaker pro tempore the house will be in order. The prayer will be offered by father conroy. Chaplain conroy let us pray. God, thank you for giving us another day. Those who omfort suffer from coronavirus. Healing. Bless and comfort those who mourn the loss of loved ones in wake of covid19. Psalmist, we turn to you. Have mercy upon us, o god, for treated harshly. Harshly all t us the day. Attackers. Re our almost high when we are afraid place our trust. We praise the word of god. Not fear. N god and do all the day our enemies foil our plans. Their every thought is of evil against us. Lie in wait for our lives. Our threats are many, o god. Unrest in Police Reform, aggressive russian and policies, a struggling economy. Our time of need. Bless the peoples house and may that is done be for your amen. R honor a
We can see our Breast Cancer exceeds california and national rates, as well as our skin cancer and our Prostate Cancer are higher than those benchmarks as well. When we look in our nonmedicare population, on the top right, we see that we are lower than benchmark for breast and cervical and skin, but the prostate is higher than the california average in the Health Service system population. The next slide is doing the same sort of comparison here, but we are looking at it by cost. Instead of looking at it by prevalence, which is what the previous slide was doing. We have, again, Breast Cancer, leukemia, and lymphoma, all of those are our costliest cancers, and we are exceeding the california benchmark and exceeding the national rate. Moving to slide 11, here we are taking a look at it from a longer to do no approach trending three years. We have 2016 through 2018, and there is a Little Orange dash line in there that shows you a trendline of how is our prevalence going over the years. So
We can see our Breast Cancer exceeds california and national rates, as well as our skin cancer and our Prostate Cancer are higher than those benchmarks as well. When we look in our nonmedicare population, on the top right, we see that we are lower than benchmark for breast and cervical and skin, but the prostate is higher than the california average in the Health Service system population. The next slide is doing the same sort of comparison here, but we are looking at it by cost. Instead of looking at it by prevalence, which is what the previous slide was doing. We have, again, Breast Cancer, leukemia, and lymphoma, all of those are our costliest cancers, and we are exceeding the california benchmark and exceeding the national rate. Moving to slide 11, here we are taking a look at it from a longer to do no approach trending three years. We have 2016 through 2018, and there is a Little Orange dash line in there that shows you a trendline of how is our prevalence going over the years. So
We can see our Breast Cancer exceeds california and national rates, as well as our skin cancer and our Prostate Cancer are higher than those benchmarks as well. When we look in our nonmedicare population, on the top right, we see that we are lower than benchmark for breast and cervical and skin, but the prostate is higher than the california average in the Health Service system population. The next slide is doing the same sort of comparison here, but we are looking at it by cost. Instead of looking at it by prevalence, which is what the previous slide was doing. We have, again, Breast Cancer, leukemia, and lymphoma, all of those are our costliest cancers, and we are exceeding the california benchmark and exceeding the national rate. Moving to slide 11, here we are taking a look at it from a longer to do no approach trending three years. We have 2016 through 2018, and there is a Little Orange dash line in there that shows you a trendline of how is our prevalence going over the years. So